SANTA CLARA, Calif. / Jan 24, 2025 / Business Wire / Agilent Technologies Inc. (NYSE: A) will release financial results for the first quarter of fiscal year 2025 after the stock market closes on Wednesday, Feb. 26. In addition, the company will host a conference call to discuss the results at 1:30 p.m. PST. To join the listen-only conference call webcast, click the link on the Events section of Agilent’s investor relations... Read More

Building the lab of the future today by enhancing lab productivity with robust and reliable automation technology SANTA CLARA, Calif. / Jan 24, 2025 / Business Wire / Agilent Technologies Inc. (NYSE: A) announced today that it will feature new automated laboratory workflow solutions at the SLAS2025 International Conference & Exhibition being held January 25-29, at the San Diego Convention Center in California. Agilent is a... Read More

SANTA CLARA, Calif. / Dec 19, 2024 / Business Wire / Agilent Technologies Inc. (NYSE: A) today announced that CEO Padraig McDonnell and CFO Bob McMahon will present at the 43 rd Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, Jan. 14, 2025, at 9:45 a.m. Pacific time. A live audio webcast and replay of the presentation will be available on the Agilent Investor Relations website . About Agilent... Read More

SANTA CLARA, Calif. / Dec 10, 2024 / Business Wire / Agilent Technologies Inc. (NYSE: A) today announced the issuing of a Class C companion diagnostic In Vitro Diagnostic Regulation (IVDR) certification for PD-L1 IHC 28-8 pharmDx (Code SK005). This CDx assay has previously been CE-IVD–marked for sales in the European Union and is now certified in accordance with the new EU Regulation for in vitro diagnostic medical devices... Read More

Delivers solid results in Q4; initiates FY25 guidance Fourth-quarter fiscal year 2024 Revenue of $1.70 billion, up 0.8% reported and down 0.3% core (1) from the fourth quarter of 2023. GAAP net income of $351 million; earnings per share (EPS) of $1.22, down 25% from the fourth quarter of 2023. Non-GAAP (2) net income of $418 million; EPS of $1.46, up 6% from the fourth quarter of 2023. Full fiscal year 2024 Revenue of $6.51... Read More

SANTA CLARA, Calif. / Nov 25, 2024 / Business Wire / Agilent Technologies Inc. (NYSE: A) today announced a new organizational structure to accelerate the company’s operational transformation to drive higher growth through a market-focused, customer-centric enterprise strategy. The new structure, including new leadership roles, takes effect immediately. “This is an important step in our transformation to become a nimbler... Read More

Columbia University scientist recognized for his contributions to sustainability and improving environmental health SANTA CLARA, Calif. / Nov 20, 2024 / Business Wire / Agilent Technologies Inc. (NYSE: A) announced today that Adeyemi Adeleye, Ph.D. , has received the Agilent 2024 Early Career Professor Award for his contribution to environmental health and sustainability, developing green analytical technologies, methods, or... Read More

SANTA CLARA, Calif. / Nov 19, 2024 / Business Wire / Agilent Technologies Inc. (NYSE: A) today announced the company has been named to Fortune’s list of Best Workplaces in the World , ranking no. 11 among 25 companies. The list is based on 7.4 million responses to the Great Place to Work survey, which represents the... Read More

Streamlined solution for mitochondrial assessment democratizes cell analysis making it accessible to more researchers SANTA CLARA, Calif. / Nov 14, 2024 / Business Wire / Agilent Technologies Inc. (NYSE: A) announces the new Mito-rOCR Assay Kit . This easy and streamlined end-to-end solution makes sophisticated analysis of mitochondrial function available to researchers of all skill levels. With this cost-effective and... Read More

Professor Isabelle Plante and Professor Bangyan Stiles recognized for their revolutionary work in cell and gene therapy research SANTA CLARA, Calif. / Nov 06, 2024 / Business Wire / Agilent Technologies Inc. (NYSE: A) today announced that Professor Isabelle Plante at Institut National de la Recherche Scientifique (INRS), and Professor Bangyan Stiles at the University of Southern California (USC) are recipients of an Agilent... Read More

Elevating lab efficiency with enhanced automation, connectivity, and sustainability capabilities SANTA CLARA, Calif. / Oct 21, 2024 / Business Wire / Agilent Technologies Inc. (NYSE: A) today announced the release of its next generation Agilent InfinityLab LC Series portfolio, which includes the 1290 Infinity III LC, 1260 Infinity III Prime LC, and 1260 Infinity III LC systems, all including the biocompatible versions. These... Read More

SANTA CLARA, Calif. / Oct 16, 2024 / Business Wire / Agilent Technologies Inc. (NYSE: A) will release financial results for the fourth quarter of fiscal year 2024 after the stock market closes on Monday, Nov. 25. In addition, the company will host a conference call to discuss the results at 1:30 p.m. PST. To join the listen-only conference call webcast, click the link on the Events section of Agilent’s investor relations... Read More

Pharmaceutical customers will benefit from a broader set of specialized CDMO capabilities SANTA CLARA, Calif. / Sep 20, 2024 / Business Wire / Agilent Technologies Inc. (NYSE: A) today announced the company has completed its acquisition of BIOVECTRA, a Canada-based contract development and manufacturing organization (CDMO)... Read More

New CLIA-certified lab ensures seamless transition from early assay development and testing to full companion diagnostics commercialization SANTA CLARA, Calif. / Sep 09, 2024 / Business Wire / Agilent Technologies Inc. , (NYSE: A) today announced the launch of its Biopharma CDx Services Lab (BCSL) in Carpinteria, California, following receipt of California State clinical laboratory license and Clinical Laboratory Improvement... Read More

SANTA CLARA, Calif. / Aug 15, 2024 / Business Wire / Agilent Technologies Inc. , (NYSE: A) today announced the release of its new Agilent J&W 5Q GC/MS Columns , representing a major advance in gas chromatography/mass spectrometry (GC/MS) column technology. Agilent has a 50-year history of innovation in gas chromatography, continually setting the standard for GC column performance. The new Agilent J&W 5Q GC/MS columns combine... Read More

MAGE-A4 IHC 1F9 pharmDx is indicated as an aid in identifying patients with synovial sarcoma for whom TECELRA ® , a MAGE-A4-directed engineered T-Cell Receptor (TCR) therapy is being considered SANTA CLARA, Calif. / Aug 02, 2024 / Business Wire / Agilent Technologies Inc. , (NYSE: A) today announced that it has received FDA approval for the use of MAGE-A4 IHC 1F9 pharmDx (SK032) as a diagnostic tool to aid in identifying... Read More

Technology helps high-throughput labs operate more efficiently SANTA CLARA, Calif. / Jul 29, 2024 / Business Wire / Agilent Technologies Inc. (NYSE: A) today announced it has acquired Sigsense Technologies , a San Francisco, California-based startup that uses artificial intelligence and power monitoring to help optimize lab operations. Financial terms of the acquisition were not disclosed. Sigsense technology is already... Read More

Expands Agilent’s end-to-end biopharma solutions that accelerate drug discovery, development, and manufacturing SANTA CLARA, Calif. / Jul 22, 2024 / Business Wire / Agilent Technologies Inc. (NYSE: A) today announced it has signed a definitive agreement to acquire BIOVECTRA, a leading specialized contract development and... Read More

SANTA CLARA, Calif. / Jul 01, 2024 / Business Wire / Agilent Technologies, Inc. (NYSE: A) today announced Bret DiMarco has been named to lead the company’s global legal organization as senior vice president and chief legal officer, as well as serving as secretary. He begins his new role with Agilent effective today. “Bret... Read More

Full-year outlook revised to reflect slower market recovery Announces plan to repurchase $0.75 billion of its common stock by end of fiscal year Board of directors authorizes new $2.0 billion share repurchase program Highlights Revenue of $1.57 billion, down 8.4% reported and 7.4% core (1) from the second quarter of 2023. GAAP net income of $308 million; earnings per share (EPS) of $1.05, up 3% from the second quarter of... Read More

New instrument delivers the full power and capability of Agilent GCs in a compact design SANTA CLARA, Calif. , May 23, 2024 /PRNewswire/ -- Agilent Technologies Inc. (NYSE: A) proudly announces the 8850 Gas Chromatograph (GC) System , a small single-channel GC that combines the legacy of the 6850 GC with the capability and system intelligence of the 8890 GC. With a focus on speed and intelligence, the 8850 GC stands poised... Read More

SANTA CLARA, Calif. / May 22, 2024 / Business Wire / Agilent Technologies, Inc. (NYSE: A) today announced a quarterly dividend of 23.6 cents per share of common stock will be paid on July 24, 2024, to all shareholders of record as of the close of business on July 2, 2024. The timing and amounts of future dividends are subject to determination and approval by Agilent’s board of directors. About Agilent Technologies Agilent... Read More

SANTA CLARA, Calif. / May 22, 2024 / Business Wire / Agilent Technologies Inc . , (NYSE: A) will showcase its latest mass spectrometry innovations at the 72nd ASMS Conference on Mass Spectrometry and Allied Topics , scheduled for June 2 - 6, 2024, in Anaheim, California. A global leader in analytical instruments, Agilent continues to drive performance and accessibility in mass spectrometry. “Agilent will make a significant... Read More

SANTA CLARA, Calif. / May 17, 2024 / Business Wire / Agilent Technologies Inc. (NYSE: A) today announced that CFO Bob McMahon will participate in a fireside chat at the Jefferies Global Healthcare Conference in New York City on Wednesday, June 5, at 8:30 a.m. EDT. Those interested in listening to the live or recorded session can access it from the Agilent Investor Relations website . The recording will be available for 90... Read More

SANTA CLARA, Calif. / May 02, 2024 / Business Wire / Agilent Technologies Inc. (NYSE: A) will release financial results for the second quarter of fiscal year 2024 after the stock market closes on May 29. In addition, the company will host a conference call to discuss the results at 1:30 p.m. PT. To join the listen-only conference call webcast, click the link on the Events section of Agilent’s investor relations website. A... Read More

SANTA CLARA, Calif. / May 01, 2024 / Business Wire / Agilent Technologies Inc. (NYSE:A) today announced that Padraig McDonnell has assumed the role of Agilent CEO, effective immediately. His appointment is part of the company’s CEO transition plan announced Feb. 21 . McDonnell is the fourth CEO in Agilent’s history and... Read More

SANTA CLARA, Calif. / Apr 29, 2024 / Business Wire / Agilent Technologies, Inc. (NYSE: A) today announced Simon May has been named president of the company’s Diagnostics and Genomics Group (DGG). May, previously executive vice president and president of the Life Science Group at Bio-Rad Laboratories, will join Agilent on May 6. “We are excited to welcome Simon May to the Agilent team,” said Padraig McDonnell, COO and... Read More

SANTA CLARA, Calif. / Apr 15, 2024 / Business Wire / Agilent Technologies Inc. (NYSE: A) today announced that its GenetiSure Dx Postnatal Assay has received European IVDR Class C Certification. This certification demonstrates that the assay meets the higher standards established by IVDR. It ensures the continued availability of this trusted qualitative assay to clinical geneticists and other healthcare professionals... Read More

Unveiling innovative automation capabilities and transformative workflows for analytical laboratories SANTA CLARA, Calif. / Apr 04, 2024 / Business Wire / Agilent Technologies Inc. (NYSE: A) today announced its participation in Analytica 2024, where it will unveil its latest innovations and transformative workflows. Analytica, the premier international trade fair for laboratory technology, analysis, and biotechnology, is... Read More

SANTA CLARA, Calif. / Apr 03, 2024 / Business Wire / Agilent Technologies Inc. (NYSE: A), a global leader in life sciences and diagnostics, announced today its participation in the American Association for Cancer Research Annual Meeting (AACR) . At the meeting, which will take place from April 5 to 10, 2024, in San Diego, CA, Agilent will highlight new cell analysis, genomics, digital pathology, and companion diagnostics... Read More

Agilent CoE supports research on how cells function and adapt, revealing new insights into biological processes SANTA CLARA, Calif. & SAN DIEGO / Apr 02, 2024 / Business Wire / Agilent Technologies Inc . (NYSE: A), a global leader in life sciences, diagnostics, and applied chemical markets, and the University of California San Diego (UC San Diego), one of the top-ranked public research universities in the world, today... Read More

SANTA CLARA, Calif. / Mar 14, 2024 / Business Wire / Agilent Technologies Inc. (NYSE: A) announced today that Joycelyn Tan, a Ph.D. student at the Wellcome-MRC Institute of Metabolic Science at the University of Cambridge , UK, has been awarded the 2024 Darlene Solomon Award . The award recognizes and supports promising female scientists working in mass spectrometry. Ms. Tan is a member of the Fazakerley group , which is... Read More

Revenue and earnings exceed Q1 guidance Full-year outlook maintained Highlights Revenue of $1.66 billion, down 5.6% reported and 6.4% core (1) from the first quarter of 2023. GAAP net income of $348 million; earnings per share (EPS) of $1.18, down 1% from the first quarter of 2023. Non-GAAP (2) net income of $380 million; EPS of $1.29, down 6% from the first quarter of 2023. Full-year revenue outlook maintained at $6.710... Read More

SANTA CLARA, Calif. / Feb 21, 2024 / Business Wire / Agilent Technologies Inc. (NYSE: A) today announced a quarterly dividend of 23.6 cents per share of common stock will be paid on April 24, 2024, to all shareholders of record as of the close of business on April 2, 2024. The timing and amounts of future dividends are subject to determination and approval by Agilent’s board of directors. About Agilent Technologies Agilent... Read More

SANTA CLARA, Calif. / Feb 13, 2024 / Business Wire / Agilent Technologies Inc. (NYSE: A) today announced the company was again named one of the Most JUST Companies in America by Just Capital and CNBC. This marks the sixth year Agilent has appeared on the exclusive list, and the fourth year the company has ranked in the top 50. The list highlights 100 companies that are performing best on business issues that matter most to... Read More

SANTA CLARA, Calif. / Feb 08, 2024 / Business Wire / Agilent Technologies Inc. (NYSE: A) announced today that it has received two prestigious awards from SelectScience: Best New Drug Discovery & Development Product of 2023 and Drug Discovery & Development Webinar of the Year. These accolades highlight Agilent’s commitment to innovation and excellence in drug discovery and development. The Agilent xCELLigence RTCA HT-BioTek... Read More

SANTA CLARA, Calif. / Feb 07, 2024 / Business Wire / Agilent Technologies Inc. (NYSE: A) today announced that CFO Bob McMahon will participate in a fireside chat at the 44 th Annual TD Cowen Health Care Conference in Boston, Massachusetts, on Monday, March 4, at 2:50 p.m. EST. A live audio webcast and replay of the presentation will be available on the Agilent Investor Relations website . About Agilent Technologies Agilent... Read More

SANTA CLARA, Calif. / Jan 30, 2024 / Business Wire / Agilent Technologies Inc. (NYSE: A) today announced an agreement with Incyte that will bring together Agilent’s expertise and proven track record in the development of companion diagnostics (CDx) to support the development and commercialization of Incyte’s hematology and oncology portfolio. The value of the companion diagnostics market is predicted to expand to nearly US... Read More

SANTA CLARA, Calif. / Jan 25, 2024 / Business Wire / Agilent Technologies Inc. (NYSE: A) will release financial results for the first quarter of fiscal year 2024 after the stock market closes on Tuesday, Feb. 27. In addition, the company will host a conference call to discuss the results at 1:30 p.m. PST. To join the listen-only conference call webcast, click the link on the Events section of Agilent’s investor relations... Read More

Automated parallel capillary electrophoresis system simplifies protein analysis SANTA CLARA, Calif. / Jan 16, 2024 / Business Wire / Agilent Technologies Inc. (NYSE: A) today announced the release of a new automated parallel capillary electrophoresis system for protein analysis – the Agilent ProteoAnalyzer system – at the 23 rd Annual PepTalk Conference , being held January 16-19 in San Diego. This new platform simplifies... Read More

SANTA CLARA, Calif. / Jan 05, 2024 / Business Wire / Agilent Technologies Inc. (NYSE: A) today announced the company has again been included in the Dow Jones Sustainability World Index and the North America Index for its strong environmental, social, and governance (ESG) performance. “It’s an honor to be named in the Dow Jones Sustainability Indices for a ninth consecutive year. I am particularly proud of our team’s progress... Read More

SANTA CLARA, Calif. / Dec 20, 2023 / Business Wire / Agilent Technologies Inc. (NYSE: A) today announced it has moved the company’s Cell Analysis Division into its Diagnostics and Genomics Group (DGG) as part of a strategy to further strengthen growth opportunities for both organizations. “We believe having the cell analysis team as part of DGG is a natural fit given the markets they serve and the clear linkages to our... Read More

SANTA CLARA, Calif. / Dec 18, 2023 / Business Wire / Agilent Technologies Inc. (NYSE: A) today announced that CEO Mike McMullen and CFO Bob McMahon will present at the 42 nd Annual J.P. Morgan Healthcare Conference in San Francisco on Tuesday, Jan. 9, 2024, at 9:45 a.m. Pacific Time. A live audio webcast and replay of the presentation will be available on the Agilent Investor Relations website . About Agilent Technologies... Read More

Empowering researchers with superior imaging performance for cutting-edge live-cell and three-dimensional applications SANTA CLARA, Calif. / Dec 04, 2023 / Business Wire / Agilent Technologies Inc. (NYSE: A) today announced the addition of water immersion and new confocal spinning disk technology to the BioTek Cytation C10 confocal imaging reader . These features improve image quality and results by reducing deleterious... Read More

Revenue at the high end of guidance and EPS exceeds guidance Fourth-quarter fiscal year 2023 Revenue of $1.69 billion, down 8.7% reported and 9.7% core (1) from the fourth quarter of 2022. GAAP net income of $475 million; earnings per share (EPS) of $1.62, up 32% from the fourth quarter of 2022. Non-GAAP (2) net income of $404 million; EPS of $1.38, down 10% from the fourth quarter of 2022. Full fiscal year 2023 Revenue of... Read More

SANTA CLARA, Calif. / Nov 17, 2023 / Business Wire / Agilent Technologies Inc. (NYSE: A) today announced that Mike McMullen, president and chief executive officer, and Bob McMahon, chief financial officer, will present at the 6 th Annual Evercore ISI HealthCONx conference on Wednesday, Nov. 29, at 10:50 a.m. ET. A live webcast and audio archive of the virtual session will be available in the News and Events section of... Read More

SANTA CLARA, Calif. / Nov 15, 2023 / Business Wire / Agilent Technologies Inc. (NYSE: A) today announced the company has increased its quarterly dividend to 23.6 cents per share of common stock, a 5% increase over the previous dividend. The quarterly dividend will be paid on Jan. 24, 2024, to all shareholders of record as of the close of business on Jan. 2, 2024. The timing and amounts of future dividends are subject to... Read More

Patients with gastric or GEJ adenocarcinoma whose tumors express PD-L1 can now be identified for potential treatment with KEYTRUDA® (pembrolizumab) using PD-L1 IHC 22C3 pharmDx (SK006) SANTA CLARA, Calif. / Nov 14, 2023 / Business Wire / Agilent Technologies Inc. (NYSE: A) today announced that it has received FDA approval for the use of PD-L1 IHC 22C3 pharmDx as a diagnostic tool to aid in identifying patients with Gastric... Read More

SANTA CLARA, Calif. / Oct 23, 2023 / Business Wire / Agilent Technologies Inc. (NYSE: A) will release financial results for the fourth quarter of fiscal year 2023 after the stock market closes on Monday, Nov. 20. In addition, the company will host a conference call to discuss the results at 1:30 p.m. PST. To join the listen-only conference call webcast, click the link on the Events section of Agilent’s investor relations... Read More

SANTA CLARA, Calif. / Sep 20, 2023 / Business Wire / Agilent Technologies, Inc. (NYSE: A) today announced that a quarterly dividend of 22.5 cents per share of common stock will be paid on Oct. 25, 2023, to all shareholders of record as of the close of business on Oct. 3, 2023. The timing and amounts of future dividends are subject to determination and approval by Agilent’s board of directors. About Agilent Technologies... Read More

Resolution Bioscience’s blood-based diagnostic tests complement Exact Sciences’ Precision Oncology portfolio, providing a more complete cancer treatment solution for patients, healthcare professionals, and biopharma partners SANTA CLARA, Calif. & MADISON, Wis. / Sep 12, 2023 / Business Wire / Agilent Technologies, Inc. (NYSE: A) and Exact Sciences Corp. (Nasdaq: EXAS), a leading provider of cancer screening and diagnostic... Read More

SANTA CLARA, Calif. / Sep 05, 2023 / Business Wire / Agilent Technologies, Inc. (NYSE: A) today announced Philip Binns has been named president of the company’s Life Sciences and Applied Markets Group (LSAG). Binns previously served as vice president and general manager of the Spectroscopy and Vacuum Solutions Division for LSAG. Binns replaces Jacob Thaysen who left the company effective today. “We’re extremely pleased to... Read More

SANTA CLARA, Calif. / Aug 24, 2023 / Business Wire / Agilent Technologies Inc. (NYSE: A) today announced the issuing of a companion diagnostic (CDx) Class C IVDR certification for PD-L1 IHC 22C3 pharmDx, Code SK006. This CDx assay has previously been CE-IVD–marked for sales in the European Union and is now certified in accordance with the new EU Regulation for in vitro diagnostic medical devices (IVDR). PD-L1 IHC 22C3... Read More

Delivers on Q3; adjusts full-year outlook to reflect softer market conditions Highlights: Reported revenue of $1.67 billion declined 2.7% year-over-year, and decreased 2.3% on a core (1) basis. GAAP net income of $111 million with earnings per share (EPS) of $0.38, down 65% from the third quarter of 2022. Non-GAAP (2) net income of $422 million with EPS of $1.43, up 7% from the third quarter of 2022. Full-year revenue is now... Read More

UCLA scientist recognized for research developing live cell analytical tools to advance bioprocess and biomanufacturing applications SANTA CLARA, Calif. / Aug 09, 2023 / Business Wire / Agilent Technologies Inc. (NYSE: A) announced today that Ajit Divakaruni, Ph.D. , has received the Agilent 2023 Early Career Professor Award. Dr. Divakaruni is an Assistant Professor in the Department of Molecular and Medical Pharmacology at... Read More

Technical University of Berlin researcher recognized for his innovative work in bioprocess engineering SANTA CLARA, Calif. / Aug 03, 2023 / Business Wire / Agilent Technologies Inc. (NYSE: A) announced that Dr. Peter Neubauer has been selected to receive a prestigious Agilent Thought Leader Award. As Chair of Bioprocess Engineering at the Technical University of Berlin , Dr. Neubauer leads innovative research to identify new... Read More

SANTA CLARA, Calif. / Jul 31, 2023 / Business Wire / Agilent Technologies Inc. (NYSE: A) today released its 2022 ESG report on the company’s work supporting customers with their sustainability initiatives while advancing its own internal high-priority ESG programs, from reducing Scope 3 emissions in the value chain to cultivating a talented, diverse, and inclusive workforce. “Agilent is committed to our customers’ success at... Read More

SANTA CLARA, Calif. / Jul 19, 2023 / Business Wire / Agilent Technologies Inc. (NYSE: A) will release financial results for the third quarter of fiscal year 2023 after the stock market closes on Tuesday, Aug. 15. In addition, the company will host a conference call to discuss the results at 1:30 p.m. PDT. To join the listen-only conference call webcast, click the link on the Events section of Agilent’s investor relations... Read More

Employees once again rate the company as a top workplace SANTA CLARA, Calif. / Jul 10, 2023 / Business Wire / Agilent Technologies Inc. (NYSE: A) today announced the company has achieved certification as a Great Place to Work®. The recognition reflects Agilent's commitment to creating a positive work environment that fosters employee engagement, innovation, teamwork and professional growth. Agilent earned Great Place to Work... Read More

Integration of Polymer Standards Service Ltd. products results in the most complete and versatile GPC/SEC portfolio on the market SANTA CLARA, Calif. / Jun 12, 2023 / Business Wire / Agilent Technologies Inc. (NYSE: A) today announced they will showcase their significantly expanded InfinityLab GPC/SEC Solution at the HPLC 2023 conference on June 18 – 22, 2023 in Düsseldorf, Germany. The Agilent InfinityLab GPC/SEC portfolio... Read More

SANTA CLARA, Calif. / Jun 08, 2023 / Business Wire / Agilent Technologies Inc. (NYSE: A) today announced the release of the Agilent BioTek 406 FX washer dispenser, a compact instrument that combines multifunctional reagent dispensing and plate-washing capabilities. The BioTek 406 FX offers expanded liquid handling features designed for integration into automated systems and standalone benchtop use. Key features of the new... Read More

SANTA CLARA, Calif. / Jun 06, 2023 / Business Wire / Agilent Technologies Inc. (NYSE: A) today announced the release of the enhanced xCELLigence RTCA Software Pro Version 2.8 , an integrated software package for running and analyzing real-time cell analysis data. This improved version enables Agilent xCELLigence Real-Time Cell Analysis (RTCA) systems in GMP-regulated facilities. The xCELLigence RTCA Software Pro enables data... Read More

SANTA CLARA, Calif. / Jun 05, 2023 / Business Wire / Agilent Technologies Inc. (NYSE: A) today announced two new liquid chromatography mass spectrometry systems (LCMS), the Agilent 6495D LC/TQ and the Agilent Revident LC/Q-TOF. Facilitating the high-end performance of the Revident LC/Q-TOF, Agilent is also announcing the new Agilent MassHunter Explorer Profiling software and the new Agilent ChemVista library manager... Read More

Self-aware solutions making mass spectrometry more accessible SANTA CLARA, Calif. / Jun 02, 2023 / Business Wire / Agilent Technologies Inc. (NYSE: A) today announced new mass spectrometry solutions on show at the 71st ASMS Conference on Mass Spectrometry and Allied Topics , being held June 4 - 8 in Houston, Texas. Agilent is a global leader in the mass spectrometry market, providing advanced, intelligent instruments... Read More

Delivers solid results; adjusts full-year guidance in an increasingly challenging market Highlights: Revenue of $1.72 billion represents 6.8% reported growth year-over-year; and up 9.5% on a core (1) basis. GAAP net income of $302 million with earnings per share (EPS) of $1.02, up 12% from the second quarter of 2022. Non-GAAP (2) net income of $377 million with EPS of $1.27, up 12% from the second quarter of 2022. Full-year... Read More

SANTA CLARA, Calif. / May 22, 2023 / Business Wire / Agilent Technologies Inc. (NYSE: A) today announced that the company will participate in Q&A sessions at the Jefferies and Goldman Sachs healthcare conferences. Below are details of each session. Jefferies Global Healthcare Conference Mike McMullen, Agilent President and CEO Wednesday, June 7 9:00 – 9:25 a.m. ET / 6:00 – 6:25 a.m. PT Goldman Sachs 44th Annual Global... Read More

SANTA CLARA, Calif. / May 18, 2023 / Business Wire / Agilent Technologies Inc. ( NYSE: A), announced today the company intends to appeal the U.S. Patent and Trademarks Office (USPTO) Patent Trial and Appeal Board’s (PTAB) Final Written Decision in connection with the Inter Partes review (IPR) of U.S. Patent Nos. 10,337,001 & 10,900,034 (the Agilent Patents). The PTAB recently reversed the USPTO’s original decision granting... Read More

SANTA CLARA, Calif. / May 17, 2023 / Business Wire / Agilent Technologies Inc. (NYSE: A) today announced that a quarterly dividend of 22.5 cents per share of common stock will be paid on July 26, 2023, to all shareholders of record as of the close of business on July 3, 2023. The timing and amounts of future dividends are subject to determination and approval by Agilent’s board of directors. About Agilent Technologies... Read More

Stanford Medicine researcher recognized for his influential work in cell biology and cancer research SANTA CLARA, Calif. / May 04, 2023 / Business Wire / Agilent Technologies Inc. (NYSE: A) announced today that Dr. Jiangbin Ye has received an Agilent Solutions Innovation Research Award (SIRA). The award supports drug discovery and development, research exploration, enhancement, and acceleration. Dr. Ye is an Assistant... Read More

SANTA CLARA, Calif. / Apr 26, 2023 / Business Wire / Agilent Technologies Inc. (NYSE: A) will release financial results and hold an earnings conference call for the second quarter of fiscal year 2023 after the stock market closes on Tuesday, May 23 at 1:30 p.m. PDT. To join the listen-only conference call webcast, click the link on the Events section of Agilent’s investor relations website. A recording of the call also will... Read More

From cancer research to diagnostic solutions SANTA CLARA, Calif. / Apr 14, 2023 / Business Wire / Agilent Technologies Inc. (NYSE: A) announced today that it will highlight new cell analysis, genomics, digital pathology, and companion diagnostics solutions at the American Association for Cancer Research Annual Meeting , held April 14-19, 2023, in Orlando, Florida. Cancer is the second most common cause of death in the US,... Read More

SureSelect Cancer CGP assay expands the number of biomarkers for solid tumor profiling with a fast and highly efficient workflow SANTA CLARA, Calif. / Apr 13, 2023 / Business Wire / Agilent Technologies Inc. (NYSE: A) today announced the launch of the Agilent SureSelect Cancer CGP Assay designed for somatic variant profiling for a broad range of solid tumor types. The pan-cancer assay design is based on an NGS panel... Read More

Innovative AI-powered interpretation methods to meet the future needs of precision medicine SANTA CLARA, Calif. / Apr 12, 2023 / Business Wire / Agilent Technologies Inc. (NYSE: A) today announced a strategic partnership with PathAI , a leading provider of AI-powered research tools and services for pathology, to deliver biopharmaceutical organizations a solution that combines Agilent’s assay development expertise and... Read More

Shenzhen Institute of Advanced Technology researcher recognized for his pioneering work in synthetic biology SANTA CLARA, Calif. / Apr 03, 2023 / Business Wire / Agilent Technologies Inc. (NYSE: A) today announced that Dr. Chenli Liu has been selected to receive an Agilent Thought Leader Award. The award will support his pioneering studies on synthetic biology, specifically research to develop a synthetic cell capable of... Read More

The award recognizes and supports promising female scientists working in mass spectrometry SANTA CLARA, Calif. / Mar 23, 2023 / Business Wire / Agilent Technologies Inc. (NYSE: A) announced today that the recipient of the 2023 Darlene Solomon Award is Kathryn Wolhuter, Ph.D., a senior postdoctoral researcher studying coronary heart disease at the Victor Chang Cardiac Research Institute in Sydney, Australia. The award was... Read More

SANTA CLARA, Calif. / Mar 10, 2023 / Business Wire / Agilent Technologies Inc. (NYSE: A) announced today a highly-anticipated end-to-end solution for digital pathology that brings together best-in-class products from Agilent , Visiopharm , Proscia® , and Hamamatsu Photonics K.K . The announcement coincides with the USCAP 112th Annual Meeting held March 11-16 at the New Orleans Ernest N. Morial Convention Center in New... Read More

SANTA CLARA, Calif. / Mar 10, 2023 / Business Wire / Agilent Technologies Inc. (NYSE: A) today announced it has partnered with Hamamatsu Photonics K.K. , a leading provider of whole slide imaging systems, to incorporate their NanoZoomer range including the S360MD Slide scanner system into the Agilent end-to-end digital pathology solution. With the addition of the NanoZoomer Slide scanner systems, which converts glass slides... Read More

SANTA CLARA, Calif. / Mar 09, 2023 / Business Wire / For the sixth consecutive year, Agilent Technologies (NYSE: A) is ranked among the top 20 in Barron’s list of America’s 100 Most Sustainable Companies . The ranking is based on the performance of the 1,000 largest publicly held companies on a variety of ESG (Environmental, Social and Governance) measures, including workplace diversity, greenhouse-gas emissions and waste.... Read More

SANTA CLARA, Calif. / Mar 09, 2023 / Business Wire / Agilent Technologies Inc. (NYSE: A) today announced the acquisition of e-MSion , an early-stage company behind the innovative electron capture dissociation (ECD) technology known as the ExD cell. The ExD cell is a compact device for mass spectrometers that enables biological researchers to develop biotherapeutic products more quickly to treat disease. This is done by more... Read More

SANTA CLARA, Calif. / Mar 08, 2023 / Business Wire / Agilent Technologies Inc. (NYSE: A) today announced a multi-year distribution agreement with Proscia ® – a leader in digital pathology – to offer a comprehensive digital diagnostic pathology system. Combining Agilent's trusted pathology staining solutions with Proscia’s Concentriq® Dx enterprise pathology platform will empower pathology labs to transform diagnostic... Read More

SANTA CLARA, Calif. / Mar 06, 2023 / Business Wire / Agilent Technologies Inc. (NYSE: A) today announced that Chief Financial Officer Bob McMahon will participate in a Q&A session at the Barclays Global Healthcare Conference in Miami Beach, Florida, on March 15 at 3:05 p.m. EST. Participants can join the webcast by accessing the link from the Agilent Investor Relations website . A replay of the session will also be available... Read More

SANTA CLARA, Calif. / Feb 28, 2023 / Business Wire / Agilent Technologies Inc. (NYSE: A) today reported revenue of $1.76 billion for the first quarter ended January 31, 2023, an increase of 5% compared to the first quarter of 2022 and up 10% on a core (1) basis. First-quarter GAAP net income was $352 million, or $1.19 per share. This compares with $283 million, or 93 cents per share, in the first quarter of fiscal year 2022.... Read More

SANTA CLARA, Calif. / Feb 27, 2023 / Business Wire / Agilent Technologies Inc. (NYSE: A) today announced the release of an on-deck thermal cycler (ODTC) that integrates with the Agilent Bravo NGS automated liquid handling platform. The optional ODTC accessory enables the Bravo platform to provide thermal cycling as part of an automated workflow for next-generation sequencing (NGS), end-point PCR, and cell-based applications.... Read More

SANTA CLARA, Calif. / Feb 24, 2023 / Business Wire / Agilent Technologies Inc. (NYSE: A) today announced their xCELLigence RTCA HT (real-time cell analysis high-throughput) platform now integrates with the BioTek BioSpa 8 Automated Incubator . Developed in response to market needs, this combination enables a higher level of workflow automation that provides novel functionality for the development of label-free... Read More

SANTA CLARA, Calif. / Feb 22, 2023 / Business Wire / Agilent Technologies Inc. (NYSE: A) today announced a quarterly dividend of 22.5 cents per share of common stock will be paid on April 26, 2023, to all shareholders of record as of the close of business on April 4, 2023. The timing and amounts of future dividends are subject to determination and approval by Agilent’s board of directors. About Agilent Technologies Agilent... Read More

SANTA CLARA, Calif. / Feb 22, 2023 / Business Wire / Agilent Technologies Inc. (NYSE: A) announced today that it will highlight a suite of automated laboratory workflow solutions at the SLAS2023 International Conference and Exhibition held February 25 through March 1 in San Diego. Agilent is also honored to receive an SLAS Lab of the Future designation, signifying going beyond automated instrumentation and bringing complete... Read More

FREDERICK, Colo. / Feb 16, 2023 / Business Wire / Leaders from Agilent Technologies Inc. (NYSE: A) today joined Colorado Governor Jared Polis and local government officials to break ground on Agilent’s $725 million investment to double manufacturing capacity of therapeutic nucleic acids in Frederick, Colorado. The investment will create more than 160 life science jobs in the Frederick area; contribute to the state’s rapidly... Read More

SANTA CLARA, Calif. / Feb 09, 2023 / Business Wire / Agilent Technologies Inc. (NYSE: A) today announced the release of new NovoExpress software that introduces integrated compliance tools for NovoCyte flow cytometer systems. The compliance-enabling features enable users to meet regulatory requirements defined in FDA 21 CFR Part 11 and Annex 11. There is immense pressure on pharmaceutical and biopharmaceutical manufacturers... Read More

SANTA CLARA, Calif. / Jan 30, 2023 / Business Wire / Agilent Technologies Inc. (NYSE: A) will release financial results for the first quarter of fiscal year 2023 after the stock market closes on Tuesday, Feb. 28. The company will host a live webcast of its earnings conference call in listen-only mode on the same day. Below are details for the webcast: Date : Tuesday, Feb. 28, 2023. Time : 1:30 p.m. Pacific time. How to Join... Read More

SANTA CLARA, Calif. / Jan 23, 2023 / Business Wire / Agilent Technologies Inc. (NYSE: A) today announced an agreement with Quest Diagnostics (NYSE: DGX), the world’s leading provider of diagnostic information services. The alliance will enable providers and patients throughout the United States to access the Agilent Resolution ctDx FIRST liquid biopsy next-generation sequencing (NGS) test. Healthcare providers can order the... Read More

Ranking Underscores Agilent’s Strong Performance on Issues of Greatest Importance to Americans Agilent Technologies Inc. (NYSE: A) is ranked 35 among the top 100 Most JUST companies , the fifth year the company has been included in the annual list by Just Capital and CNBC. Agilent also earned the top ranking in its sector for industry-leading performance regarding treatment of employees, customers and the environment. Just... Read More

Agilent Technologies Inc. (NYSE: A) today announced that its board of directors has approved a new share repurchase program. The 2023 program authorizes the purchase of up to $2 billion of the company’s common stock. “Agilent is committed to balanced capital deployment that drives growth and helps deliver strong returns for shareholders,” said Bob McMahon, Agilent chief financial officer. “This share repurchase program is a... Read More

Investment will double capacity to produce active pharmaceutical ingredients used in therapeutics for a broad range of diseases Agilent Technologies Inc. ( NYSE: A) today announced it is investing approximately $725 million to double manufacturing capacity of therapeutic nucleic acids in response to rapid growth of the $1... Read More

Will commercialize end-to-end workflow solutions for tissue biomarker analysis in companion diagnostic development Agilent Technologies, Inc. (NYSE: A) today announced a partnership with Akoya Biosciences, Inc. (Nasdaq: AKYA), The Spatial Biology Company®, to develop multiplex-immunohistochemistry diagnostic solutions for tissue analysis and to commercialize workflow solutions for multiplex assays in the clinical research... Read More

Innovative chemistries enable simultaneous genomic and epigenomic profiling on the same sample, yielding greater insights for precision medicine Agilent Technologies Inc. (NYSE: A) today announced the acquisition of Avida Biomed, an early-stage life sciences company that develops high-performance target enrichment workflows with unique capabilities for clinical researchers utilizing next-generation sequencing (NGS)... Read More

SANTA CLARA, Calif.--( BUSINESS WIRE )-- Agilent Technologies Inc. (NYSE: A) announced today that the U.S. Food and Drug Administration (FDA) has approved Agilent Resolution ctDx FIRST as a companion diagnostic (CDx) to identify advanced non-small cell lung cancer (NSCLC) patients with KRAS G12C mutations who may benefit from treatment with KRAZATI TM (adagrasib). This is the first liquid biopsy NGS assay approved by the FDA... Read More

SANTA CLARA, Calif.--( BUSINESS WIRE )-- Agilent Technologies Inc . (NYSE: A) today announced the opening of a new Customer Experience Center (CEC) in Lexington, MA, focused on solutions from Agilent genomics and diagnostics product portfolios. The facility will serve as a regional hub for Agilent representatives to showcase and demonstrate both product capabilities and complete workflow solutions to customers. Hands-on... Read More